Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronit Mazor

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|July 23, 2020
Immunogenicity of Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A: Causes, Consequences, and MitigationRonit Mazor, Ira Pastan
The AAPS Journal|September 10, 2025
Can Sex-based Variations in the Immune Responses to AAV Gene Therapy Affect Safety and Efficacy? A Review of Current UnderstandingLeila Abdelhamid, Ronit Mazor
Cellular Immunology|September 15, 2018
Anti-drug antibodies to LMB-100 are enhanced by mAbs targeting OX40 and CTLA4 but not by mAbs targeting PD1 or PDL-1Ronit Mazor, Emily King, Ira Pastan
Immunological Reviews|February 12, 2016
Immunogenicity of therapeutic recombinant immunotoxinsRonit Mazor, Masanori Onda, Ira Pastan
Frontiers in Immunology|July 20, 2023
Low cross reactivity between wild type and deamidated AAV can lead to false negative results in immune monitoring T-cell assaysSo Jin Bing, Stephanee Warrington, Ronit Mazor
The American Journal of Pathology|June 6, 2018
Strategies to Reduce the Immunogenicity of Recombinant ImmunotoxinsRonit Mazor, Emily M King, Ira Pastan
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant ImmunotoxinEmily M King, Ronit Mazor, Nicolas Çuburu, et al.
Journal of Immunological Methods|June 10, 2015
Poor correlation between T-cell activation assays and HLA-DR binding prediction algorithms in an immunogenic fragment of Pseudomonas exotoxin ARonit Mazor, Chin-Hsien Tai, Byungkook Lee, et al.
Toxins|November 17, 2018
SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma TumorsYasmin Leshem, Emily M King, Ronit Mazor, et al.
Molecular Cancer Therapeutics|April 27, 2018
Improving the <i>In Vivo</i> Efficacy of an Anti-Tac (CD25) Immunotoxin by <i>Pseudomonas</i> Exotoxin A Domain II EngineeringGilad Kaplan, Ronit Mazor, Fred Lee, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|July 23, 2020
Immunogenicity of Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A: Causes, Consequences, and MitigationRonit Mazor, Ira Pastan
The AAPS Journal|September 10, 2025
Can Sex-based Variations in the Immune Responses to AAV Gene Therapy Affect Safety and Efficacy? A Review of Current UnderstandingLeila Abdelhamid, Ronit Mazor
Cellular Immunology|September 15, 2018
Anti-drug antibodies to LMB-100 are enhanced by mAbs targeting OX40 and CTLA4 but not by mAbs targeting PD1 or PDL-1Ronit Mazor, Emily King, Ira Pastan
Immunological Reviews|February 12, 2016
Immunogenicity of therapeutic recombinant immunotoxinsRonit Mazor, Masanori Onda, Ira Pastan
Frontiers in Immunology|July 20, 2023
Low cross reactivity between wild type and deamidated AAV can lead to false negative results in immune monitoring T-cell assaysSo Jin Bing, Stephanee Warrington, Ronit Mazor
The American Journal of Pathology|June 6, 2018
Strategies to Reduce the Immunogenicity of Recombinant ImmunotoxinsRonit Mazor, Emily M King, Ira Pastan
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant ImmunotoxinEmily M King, Ronit Mazor, Nicolas Çuburu, et al.
Journal of Immunological Methods|June 10, 2015
Poor correlation between T-cell activation assays and HLA-DR binding prediction algorithms in an immunogenic fragment of Pseudomonas exotoxin ARonit Mazor, Chin-Hsien Tai, Byungkook Lee, et al.
Toxins|November 17, 2018
SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma TumorsYasmin Leshem, Emily M King, Ronit Mazor, et al.
Molecular Cancer Therapeutics|April 27, 2018
Improving the <i>In Vivo</i> Efficacy of an Anti-Tac (CD25) Immunotoxin by <i>Pseudomonas</i> Exotoxin A Domain II EngineeringGilad Kaplan, Ronit Mazor, Fred Lee, et al.
Pageof 3